chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a certified medical assistant concerning a 15 year old female with allergic rhinitis who on 26-Jan-2009 was vaccinated with the first dose of GARDASIL IM 0.5ml (lot# 651952/ 1129X). Concomitant therapy included NASONEX. On 26-Jan-2009 evening the patient developed a fever of 101.5 degrees F. a migraine-like headache, nausea, light sensitivity. She mentioned that the patient "almost pass out every time she stood up". There was no itching or hives noted. On an unknown date, the patient recovered from the events. The nurse mentioned that the patient's mother has declined to allow additional doses of GARDASIL for her daughter. The patient sought medical attention from her mother. Additional information has been requested.
throwing up; Sweating; Lightheaded; the patient can barely speak to her/she just whispered it; This is a spontaneous report from a contactable consumer. An 86-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EC9231, expiry date Apr2021), intramuscular in the left arm on 09Jan2021 at single dose for COVID-19 immunisation. Medical history included COVID-19 from 13Apr2020 and she got a plasma donation, in Apr2020 because she was not in good shape when she had COVID. There were no concomitant medications. The patient previously took first dose of bnt162b2 (lot number and expiry date not reported) on an unspecified date at single dose for COVID-19 immunisation. The reporter said that the patient's doctor told her to still get the COVID vaccine and on 10Jan2021, she had been throwing up, sweating, and lightheaded and these were the side effects with the second dose. The caller stated that no one else had side effects like these. It was reported that the patient had no other family and the reporter felt really bad for the patient and wanted to get her some sort of information. The patient said that she was feeling a little better than she did last night, but she was laying in bed. The patient's symptoms started yesterday 10Jan2021, the next day after receiving the vaccine. The reporter said that the patient can barely speak to her. She said that the patient said that she was feeling a little better, but she just whispered it. The reporter asked if it was because the patient had antibodies. Clinical outcome of the events was unknown.
patient received covid 19 vaccine and then proceeded to waiting area for 15 minute watch period. After a few minutes of waiting his companion alerted us that he was fainting and she started to hold him in place. I  then came out to assist in placing him on the floor. Technician also assisted along with companion. We successfully placed him on the floor and within a few seconds he regained consciousness. Called 911 and within 10 minutes or so paramedics arrived to the scene. Paramedics then placed him on stretcher and took him away.
she got her first shot on 19th march( more that 36 days have passed); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she got her first shot on 19th march( more that 36 days have passed)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she got her first shot on 19th march( more that 36 days have passed)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she got her first shot on 19th march( more that 36 days have passed)) outcome was unknown. Not Provided          No concomitant medication was reported.  Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Nonsignificant Follow-up
Pt initially stated she started with cough, congestion and nausea a few days after injection. Process has furthered to what she and her physician believe is shingles. Pt now has painful lesions on body.
? After her shot in the afternoon, she sat outside for 15 minutes.  She came back in and said her throat is warm and scratchy, and her left hand felt cold.  ? I escorted her over to the ER and she was checked in.  I then went right back to EOHD since we were so busy.  ? Around 4pm in the afternoon after we closed EOHD, I went back to the ER.  She was recovering and doing fine.  Her ER nurse did have a question about receiving the 2nd dose, and I provided the same answer that Dr. provided to other Dr. about taking an Allegra 30 minutes before the second dose.
Report 20020020031 describes hepatitis C in a 47 year old male who received hepatitis A vaccine inactivated (Havrix). The vaccinee received an injection of Havrix on 01/25/2002; it was not known if he had received previous injections of Havrix. At the time of immunization, "AST was inthe 400s" and ALT concentration was 528 U/L. the vaccinee was hospitalized on 01/26/2002, one day post-immunization, with a diagnosis of hepatitis C. Laboratory analysis performed on 01/29/2002 revealed AST "in the 500s" and ALT 614 U/L.
Itching overnight, but has resolved. only rash remains, above elbow, not just injection site.
Pain in arm; Ache; Upper back pain; Fatigue; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), PAIN (Ache), BACK PAIN (Upper back pain), FATIGUE (Fatigue) and PYREXIA (Low grade fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    NO INFORMATION WAS ADDED.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm), PAIN (Ache), BACK PAIN (Upper back pain), FATIGUE (Fatigue) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (Pain in arm), PAIN (Ache), BACK PAIN (Upper back pain), FATIGUE (Fatigue) and PYREXIA (Low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO CONCOMITAN DRUGS AND TREATMENT MEDICATIONS WERE USED   Reporter did not allow further contact
Pt noted large swelling in right arm following the 3rd dose of vaccine, greater than prior doses. Hard, red and about 2 inches in diameter.
Extreme tinnitus, screaming in my head at a 8.5 level of noise and constant migraine
morning p/vax pt devel scratchy throat;hr later pt stated afraid & wanted to hurt self;was combative, looked psychotic & had a contusion from banging head against the wall;pt hosp;stated afraid might hurt other & she was Mary Queen of scott
patient got the flu was after he had the flu shot; Initial information received on 13-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer (patients parents).  This case involved a male patient of unknown age who got the flu was after he had the flu shot (influenza), while patient received vaccines INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received INFLUENZA VACCINE [lot number: unknown and expiration date: unknown] at an unknown dose via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, patient got the flu was after he had the flu shot (influenza), (latency: unknown) following the administration of suspect vaccine.  No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  Outcome of the events were unknown.  There will be no information available regarding batch number in this case.
Patient received vaccine on 4.6.2021 and developed an extensive rash on 4.21.2021 which she had never experienced before on the torso with some extension to the back. She also reported some leg pain which occurred on 4.22.2021 along with fatigue. The rash was unsightly but not bothersome other than the appearance.
Fever, Chills, Headache, fatigue- recovered after 36 hours.    Extreme Arm pain, arm swelling, shoulder pain (9 out of 10 when in motion,  7 out of 10 when in motion ), shoulder tendonitis, lack of motion in shoulder, grinding, clicking and popping noises in shoulder- swelling  went down after 48 hours with ice, heat and pain medication however, other shoulder related injury, no change in 48 hours
11SEP92 death reported by MD pt DOA ER 430PM on 4SEP92; autopsy findings lung petechiae - SIDS; no other abnormal findings; pt was fussy & had fever; pt noted not breathing; CPR initiated;
On the 3rd day after shot, swollen lymph node and jaw pain on the same side as injection. Swelling went down after a few days. 8 days after injection, pinched nerve or muscle strain type pain in left side of neck/collarbone and stiff neck and pain. 2 weeks later now, still have pain, it's getting better but has no gone away completely.
Tinnitus in both ears. Constant ringing while awake. Consulted PCP and ENT specialist. No obvious cause found.
Chills; Fever; Headache; Vomiting; Diarrhea; Body aches; This case was reported by a consumer via call center representative and described the occurrence of chills in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included adalimumab (Humira).   On 1st October 2019, the patient received the 1st dose of Shingrix (intramuscular). On 1st October 2019, less than a day after receiving Shingrix, the patient experienced chills, fever, headache, vomiting, diarrhea and general body pain. On an unknown date, the outcome of the chills, fever, headache, vomiting, diarrhea and general body pain were recovering/resolving.   It was unknown if the reporter considered the chills, fever, headache, vomiting, diarrhea and general body pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was on Humira and received Shingrix on left deltoid and experience fever, chills, headache, vomiting, diarrhea, and body aches. She was feeling much better at the time of reporting. The reporter consented to follow up.
Lower GI bleed - colonoscopy shows a bleeding polyp which was completely removed bleeding stopped GI is okay with her going home.  She is not to start her Eliquis until tomorrow I would hold her aspirin till follow-up.  We will start iron she is to have blood work in a week. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine,
This spontaneous report as received from a medical assistant refers to a three unspecified patients of unknown gender and age in September 2014 (reported as since the temperature event), the patients were vaccinated with a doses of GARDASIL (dose, dose number, route, lot/batch number, expiration date were not reported) that were improperly stored on 08-SEP-2014. No adverse effects were reported.  Follow-up information has been received from he reporting medical assistant, who provided patients' identifiers (age and gender), dates of vaccinations and lot numbers.  This report concerns a 63 years old male patient. No information of his medical history, concurrent conditions or concomitant drugs was provided. It was reported that the PNEUMOVAX23 underwent the temperature excursion on 08-AUG-2014. On 18-AUG-2014, the patient received a dose of PNEUMOVAX23 which underwent temperature excursion (dose, site and route of administration unknown, lot # J008799, expiration date 16-APR-2014). This is one of several reports from the same reporter. Additional information has been requested.
Armpit rash in both armpits within 24 hours. Rash was more significant in the arm of the injection. It was not painful, I didn't notice it was there until looking in the mirror. It was gone by hour 36.
FEVER; This spontaneous report received from a patient concerned a 43 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, once a total administered, on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 106 degrees. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on MAR-2021. This report was non-serious.
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 28-FEB-2017, the patient was vaccinated with an expired dose of PNEUMOVAX23 (dose and frequency: 0.5 ml, once; lot # L024132, expiry date: 21-JAN-2017) intramuscularly for prophylaxis. No adverse effects were reported. Additional information has been requested.
Information has been received from a health professional concerning a female (age not reported) who on an unspecified date was vaccinated IM with a dose of Gardasil (lot #, site of administration not reported). Immediately after vaccination, the patient experienced moderate inflammation at the site of injection characterised by redness, warmth and pain. Subsequently the patient experienced axillary adenopathy. At the time of the report, the duration of the events and the outcome of was not reported. Other business partner numbers include: E2007-07547. Additional information has been requested.
Nausea, myalgia, injection site pain, malaise, diarrhea,  chills, joint pain, headache, nasal congestion,
Bilateral lower extremity ?pins & needles and electric shock? intermittently with numb sensation
Approximately 2 weeks after getting the vaccine the injection site is again raised, red, warm and now itchy.
Patient was given two DTaPs, and two Hep A vaccines instead of one DTaP, and one Hep A. Patient is a twin.  No symptoms as yet.
Patient received a Pneumovax 23 2/08/20. Pt called the pharmacy on 3/21/20 to report the adverse reaction. Pt stated he experienced swelling at the injection site along with numbness on the feet a little over 24hrs after administration. Pt stated we went to the hospital where he was treated with steroids and an unknown injected or IV medication. Pt stated intensity of numbness, reported as pins and needles, worsened 2-3 weeks prior to 3/21/20.
patient broke out in hives about 4 days after receiving vaccine. Hives are still covering patients body as of 12/14/19 (4 months later) and patient has been going to a specialist to get xoliar injections
Felt unwell, weak VERY HOT, headache.  Had fever of over 101 - Tylenol.
Severe left bicep pain radiates into left trapezius and cervical neck, Loss of large amout of hair on head, chronic H/A
This spontaneous report as received from a health professional refers to a patient of unknown age. The health professional reported that on an unknown date about 10 patients was vaccinated with PEDVAXHIB, intramuscular that was improperly exposed to 60F for 14 hours. No known adverse effects. All of the data listed here was reconfirmed with the reporter. Additional information has been requested.
Migraine - resolved by 9PM Chills - intermittent for 1.5 days Low fever - intermittent for 1 day Aches - 2 days Mild injection site soreness - 3 days
Pneumovax 23 given instead of Prevnar 13, no reactions. Dr. notified. Attempted to notify Parent x 4, voicemail not set up to receive messages. Spoke with relative, he stated he would give parent the message to call HD.
Patient was experiencing muscle pain on both arms, headache, queasy, and fatigue in the evening, and noticed a few red spots near the injection site on 9/6, (2 days after the injection was given).
immediately following injection, , nausea (stayed onsite for 15 min after shot), - the next 48 hours, muscle achiness,  no/low energy, fatigue
Patient received moderna vaccine on 3/17/21, 4/14/21 and 11/16/21. COVID positive on 5/6/22. Presented to ER on 5/12/22. admitted on 5/12/2022 with shortness of breath, worsening cough             Diagnosis with COVID-19 on 05/06/2022.  Received prednisone at home. SpO2 84% on arrival.  Requiring NC oxygen             CT chest-Hypersensitivity pneumonitis vs NSIP vs atypical pneumonia.  Vaccinated against COVID-19, immunocompromised.              Started on dexamethasone, antibiotic, remdesivir.  Clinically improving.  Short of breath resolved.  Cough significantly improved.  6 minute walk test done.  No recommendation for home oxygen.             No new voiced concerns. Patient is medically stable to be discharge Home with incentive spirometer, pulse oximeter.  Follow-up with PCP and oncologist. Discharged on 5/15/22
Positive for COVID-19 and started having symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Positive for COVID-19 and started having symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced COVID-19 (Positive for COVID-19 and started having symptoms). The patient was treated with BAMLANIVIMAB for COVID-19, at a dose of 1 dosage form. At the time of the report, COVID-19 (Positive for COVID-19 and started having symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Drug exposure during pregnancy; sore arm; facial numbness; headache; muscle ache; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy), PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (facial numbness), HEADACHE (headache) and MYALGIA (muscle ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy), PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (facial numbness), HEADACHE (headache) and MYALGIA (muscle ache). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Drug exposure during pregnancy) had resolved and PAIN IN EXTREMITY (sore arm), HYPOAESTHESIA (facial numbness), HEADACHE (headache) and MYALGIA (muscle ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Non-significant Follow up added. Reporter contact details updated.
Severe pain at injection site. Severe cough x 90 mins. Lethargy x 2 days.
PATIENT RECEIVED MODERNA 1 ST DOSE AT ANOTHER RETAIL AND WAS NOT AWARE THAT HE WAS GIVEN PFIZER AS DOSE 2. HE WENT HOME AND REALIZED THAT HE WAS GIVEN PFIZER.
25 hrs after injection I was tired, muscle and joint aches, low grade fever, slight stomach upset and had moderate lymph node pain( below armpit of injection arm).
Throat tightness; This is a spontaneous report from a contactable pharmacist. A 64-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via an unspecified route of administration on 17May2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient was resulted in throat tightness 15 minutes after dose in May2021. Asking for recommendation on whether patient should receive second dose. Outcome of the event was unknown.  Follow-up attempts are needed. Further information is expected.
headache; This is a spontaneous report from a contactable consumer (patient).   A 53-year-old non-pregnant female patient received BNT162B2 first dose (Pfizer-Biontech Covid19 vaccine, Batch/Lot no: EL3247) via an unspecified route of administration and administrated in left arm on 26Jan2021 at 9:30 as single dose for COVID-19 immunization at workplace clinic facility. The patient medical history included high blood pressure. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), venlafaxine hydrochloride (EFFEXOR), mirabegron (MYRBETRIC) and amlodipine besilate (NORVASC). Patient not had covid prior vaccination. On 27Jan2021 at 12:00, patient experienced headache. Patient not tested for covid post vaccination. Patient not received treatment for the event. At the time of this report event outcome was unknown.   Follow-up attempts are completed. No further information is expected.